闭塞性动脉硬化症

  • 网络Arteriosclerosis obliterans;ASO;Arteriosclerosis Obliterans,ASO
闭塞性动脉硬化症闭塞性动脉硬化症
  1. 目的:探讨益气活血中药方剂对早期闭塞性动脉硬化症(ASO)的治疗作用。

    To explore therapeutic action of the formula for supplementing Qi and activating blood circulation on early arteriosclerosis obliterans ( ASO ) .

  2. 结论康复护理应用于闭塞性动脉硬化症能改善患者肢体血运功能,疾病控制,症状缓解,抑郁和焦虑障碍减轻,日常生活能力增强,生活质量明显提高。

    Conclusion Rehabilitation and nursing care for the patients with arteriosclerosis obliterans could improve the blood supply of extremities , control illness , relief symptoms , alleviate depression and anxiety and promote daily living ability so as to increase the quality of living .

  3. 闭塞性动脉硬化症如脉压(PP)是动脉硬化的晚期标志;

    For example , pulse pressure ( PP ) is an advanced sign of afternoon arteriosclerosis ;

  4. 川芎嗪治疗闭塞性动脉硬化症及其对血管内皮细胞作用的临床观察

    Effect of Ligustrazine Injection on Vascular Endothelial Cell of the Patients with Arteriosclerosis Obliterans

  5. 补阳还五汤加减配合溶栓胶囊治疗闭塞性动脉硬化症73例

    Treatment of 73 Cases of Arteriosclerosis Obliterans with Modified Buyang Huanwu Decotion and Thrombolytic Capsule

  6. 目的观察闭塞性动脉硬化症康复护理的效果。

    Objective To observe the therapeutic effects of rehabilitation and nursing care for arteriosclerosis obliterans .

  7. 阿魏酸钠对闭塞性动脉硬化症患者白细胞自发活化及表面粘附分子表达的影响

    Effect of Sodium Ferulate on Leucocyte Spontaneous Activation and Surface Adhesion Molecule Expression in Arteriosclerosis Obliterans Patients

  8. 目的观察益气通脉法治疗闭塞性动脉硬化症临床疗效。

    Objective To observe the therapeutic effect of benefiting Qi and invigorating pulse therapy on arteriosclerosis obliterans .

  9. 背景:血管再生疗法是重症缺血性心脏病和闭塞性动脉硬化症的新治疗措施。

    Background : neovascularization is a new measure of treatment for ischemic heart disease and occlusive atherosclerosis .

  10. 闭塞性动脉硬化症动脉血管监测指标与中医辨证分型相关性研究下肢动脉硬化闭塞症的外科治疗观察

    Research on the Correlation between Arterial Monitoring Indicators and the Syndrome of Arteriosclerosis Obliterans The Observation of Surgical Treatment in Lower Extremities Arteriosclerosis Obliterans

  11. 中药熏洗法对闭塞性动脉硬化症血瘀证患者血小板活化分子颗粒膜蛋白基因的调控

    Platelet activating factor granule membrane protein regulated by the xunxi fa of Chinese herbal medicine in patients with arteriosclerosis obliterans of blood stasis syndrome type